267 related articles for article (PubMed ID: 31089160)
21. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
22. Cervicovaginal microbiota dysbiosis correlates with HPV persistent infection.
Qingqing B; Jie Z; Songben Q; Juan C; Lei Z; Mu X
Microb Pathog; 2021 Mar; 152():104617. PubMed ID: 33207260
[TBL] [Abstract][Full Text] [Related]
23. Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population.
Ritter DB; Kadish AS; Vermund SH; Romney SL; Villari D; Burk RD
Am J Obstet Gynecol; 1988 Dec; 159(6):1517-25. PubMed ID: 2849881
[TBL] [Abstract][Full Text] [Related]
24. Identification of protein biomarkers for cervical cancer using human cervicovaginal fluid.
Van Raemdonck GA; Tjalma WA; Coen EP; Depuydt CE; Van Ostade XW
PLoS One; 2014; 9(9):e106488. PubMed ID: 25215525
[TBL] [Abstract][Full Text] [Related]
25. Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer.
Shen J; Sun H; Chu J; Gong X; Liu X
Infect Agent Cancer; 2024 Apr; 19(1):13. PubMed ID: 38641803
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of HPV 16 PCR detection in self- compared with clinician-collected samples in women referred for colposcopy.
Daponte A; Pournaras S; Mademtzis I; Hadjichristodoulou C; Kostopoulou E; Maniatis AN; Messinis IE
Gynecol Oncol; 2006 Nov; 103(2):463-6. PubMed ID: 16626791
[TBL] [Abstract][Full Text] [Related]
27. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
Učakar V; Poljak M; Oštrbenk A; Klavs I
J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
[TBL] [Abstract][Full Text] [Related]
28. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
Castle PE; Hillier SL; Rabe LK; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Burk RD; Rodriguez AC; Alfaro M; Hutchinson ML; Morales J; Schiffman M
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1021-7. PubMed ID: 11588127
[TBL] [Abstract][Full Text] [Related]
29. [The significance of human papillomavirus infection in cervix cancer and its preliminary stages (including other HPV-induced genital lesions)].
Czerwenka KF; Schön HJ
Gynakol Rundsch; 1989; 29 Suppl 3():44-53. PubMed ID: 2560451
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
[TBL] [Abstract][Full Text] [Related]
31. Papillomavirus and cervical cancer: a clinical and laboratory study.
Zhang WH; Coppleson M; Rose BR; Sorich EA; Nightingale BN; Thompson CH; Cossart YE; Bannatyne PM; Elliott PM; Atkinson KH
J Med Virol; 1988 Oct; 26(2):163-74. PubMed ID: 2846776
[TBL] [Abstract][Full Text] [Related]
32. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.
Berti FCB; Pereira APL; Cebinelli GCM; Trugilo KP; Brajão de Oliveira K
Cytokine Growth Factor Rev; 2017 Apr; 34():1-13. PubMed ID: 28365229
[TBL] [Abstract][Full Text] [Related]
33. Discriminating high-risk cervical Human Papilloma Virus infections with urinary biomarkers via non-targeted GC-MS-based metabolomics.
Godoy-Vitorino F; Ortiz-Morales G; Romaguera J; Sanchez MM; Martinez-Ferrer M; Chorna N
PLoS One; 2018; 13(12):e0209936. PubMed ID: 30592768
[TBL] [Abstract][Full Text] [Related]
34. Clonal history of papillomavirus-induced dysplasia in the female lower genital tract.
Vinokurova S; Wentzensen N; Einenkel J; Klaes R; Ziegert C; Melsheimer P; Sartor H; Horn LC; Höckel M; von Knebel Doeberitz M
J Natl Cancer Inst; 2005 Dec; 97(24):1816-21. PubMed ID: 16368943
[TBL] [Abstract][Full Text] [Related]
35. AgNOR Pleomorphic Count as a Tumor Marker in Cervical Carcinogenesis and Feasibility of Its Introduction in Cervical Cancer Screening Programs to Discriminate High-Risk Cases of Squamous Intraepithelial Lesions of the Cervix.
Srivastava AN; Misra JS; Singh U; Khan M; Raza S
Acta Cytol; 2019; 63(5):371-378. PubMed ID: 31067531
[TBL] [Abstract][Full Text] [Related]
36. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
[TBL] [Abstract][Full Text] [Related]
37. [Human papillomavirus infection and carcinogenesis of cancer of the uterine cervix. I. Pathomorphology of 357 cervical tissues].
Shu LL; Yang XZ; Zheng SJ
Zhonghua Zhong Liu Za Zhi; 1987 Jul; 9(4):276-8. PubMed ID: 2824150
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus (HPV) infection, HIV infection and cervical cancer in Tanzania, east Africa.
ter Meulen J; Eberhardt HC; Luande J; Mgaya HN; Chang-Claude J; Mtiro H; Mhina M; Kashaija P; Ockert S; Yu X
Int J Cancer; 1992 Jun; 51(4):515-21. PubMed ID: 1318265
[TBL] [Abstract][Full Text] [Related]
39. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia.
Fife KH; Cramer HM; Schroeder JM; Brown DR
J Med Virol; 2001 Aug; 64(4):550-9. PubMed ID: 11468743
[TBL] [Abstract][Full Text] [Related]
40. Cervical Local Immune Response for High-Risk Human Papillomavirus Infection: Involvement With Cervical Mucus SLPI Proteins.
Sahin E; Madendag Y; Sahin ME; Madendag IC; Acmaz G; Karakukcu C; Karaman H; Muderris II
Cancer Control; 2018; 25(1):1073274818798598. PubMed ID: 30180755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
